Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05828966 |
Other study ID # |
001 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
February 15, 2023 |
Est. completion date |
December 20, 2023 |
Study information
Verified date |
June 2024 |
Source |
Shaheed Zulfiqar Ali Bhutto Medical University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Preterm labor is defined as regular contractions of the uterus resulting in changes in the
cervix (effacement and dilatation) that start before 37 weeks of pregnancy. (1) Although
preterm labor constitutes only 10% of total labors, yet 70% of infant's mortality is related
to prematurity. It is therefore one of the international indices in assessment of health
condition worldwide. Human Chorionic Gonadotropin (H.C.G.) is a heterodimeric glycoprotein
produced primarily in the placenta and has multiple endocrines, paracrine and
immunoregulatory actions. (3) The importance of H.C.G. in maintenance of early pregnancy has
been widely accepted, reports have highlighted a potential role of H.C.G. in maintaining
uterine quiescence in the third trimester. H.C.G. exerts a potent concentration dependent
inhibitory effect on human myometrial contractions. (4) Recent data suggests that H.C.G.
might have a role as an endogenous tocolytic agent in normal pregnancy. A significant
decrease in serum H.C.G. level was found 2-3 weeks before the spontaneous onset of labour.
This might contribute to increasing the contractility in the uterine muscle and gradually
initiating the onset of labour. (5)
Description:
Preterm labor is defined as regular contractions of the uterus resulting in changes in the
cervix (effacement and dilatation) that start before 37 weeks of pregnancy. (1) Although
preterm labor constitutes only 10% of total labors, yet 70% of infant's mortality is related
to prematurity. It is therefore one of the international indices in assessment of health
condition worldwide. Factors that increase the risk of preterm birth include history of
previous preterm birth, short cervix, short time between pregnancies, teenage pregnancy,
history of certain types of surgery on the uterus or cervix, certain pregnancy complications,
such as multiple pregnancy and vaginal bleeding and lifestyle factors such as low
pre-pregnancy weight, smoking during pregnancy, and substance abuse during pregnancy.
Preterm labor can be diagnosed clinically only when changes in the cervix are found after
pelvic examination along with contractions also may be monitored. A transvaginal ultrasound
exam may be done to measure the length of your cervix. Tocolytics are drugs used to delay
delivery for a short time (up to 48 hours). They may allow time for corticosteroids or
magnesium sulfate to be given or for you to be transferred to a hospital that offers
specialized care for preterm infants. (1,2) Tocolytic agents are β- HCG, MgSO4, nifedipine,
β-agonists(salbutamol) and atosiban. Use of salbutamol is of limited use because of many
cardiovascular complications i.e., ventricular arrythmia, hypertension and hyperglycemia
while atosiban is expensive and not available in Pakistan.
Human Chorionic Gonadotropin (H.C.G.) is a heterodimeric glycoprotein produced primarily in
the placenta and has multiple endocrines, paracrine and immunoregulatory actions. (3) The
importance of H.C.G. in maintenance of early pregnancy has been widely accepted, reports have
highlighted a potential role of H.C.G. in maintaining uterine quiescence in the third
trimester. H.C.G. exerts a potent concentration dependent inhibitory effect on human
myometrial contractions. (4) Recent data suggests that H.C.G. might have a role as an
endogenous tocolytic agent in normal pregnancy. A significant decrease in serum H.C.G. level
was found 2-3 weeks before the spontaneous onset of labour. This might contribute to
increasing the contractility in the uterine muscle and gradually initiating the onset of
labour. (5) Following I.M. injection, peak concentration of H.C.G. occurs about 6 hrs after a
dose. It is distributed primarily to gonads. Blood concentration declines in a biphasic
manner, with a half-life between about 6 and 11 hrs and 23 to 38 hrs respectively. About 10
to 12% of an IM dose is excreted in urine within 24 hours. (6)